<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02095730</url>
  </required_header>
  <id_info>
    <org_study_id>CXL-CHR 1</org_study_id>
    <nct_id>NCT02095730</nct_id>
  </id_info>
  <brief_title>Corneal Cross-Linking Comparing Variables</brief_title>
  <official_title>Study of Safety and Efficacy of Photochemically Induced Collagen Cross-Linking at an Irradiance of 18 mW/cm2 as Constant or Pulsed Treatment in Eyes With Unstable Corneas Due to Keratoconus, Ectasia, or Post-Incisional Refractive Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Crowd Health Research, LTD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Crowd Health Research, LTD</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the Safety and Efficacy of Corneal Cross Linking in
      a Continuous Beam versus Pulsed Treatments across epithelium on and epithelium off surfaces.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>2 years</time_frame>
    <description>Uncorrected visual acuity</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Unstable Corneas</condition>
  <arm_group>
    <arm_group_label>Epi-On Continuous</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous beam of UV light treating cornea with surface epithelium present</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epi-Off Continuous</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous beam of UV light treating cornea without surface epithelium present</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epi-On Pulsed</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pulsed beam of UV light treating cornea with surface epithelium present</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epi-Off Pulsed</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pulsed beam of UV light treating cornea without surface epithelium present</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epithelium-On Riboflavin</intervention_name>
    <description>Riboflavin 0.1% Phosphate Sodium solution with Benzalkonium Chloride Preservative</description>
    <arm_group_label>Epi-On Continuous</arm_group_label>
    <arm_group_label>Epi-On Pulsed</arm_group_label>
    <other_name>Vitamin B2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epithelium-Off Riboflavin</intervention_name>
    <description>Riboflavin 0.1% Phosphate Sodium solution</description>
    <arm_group_label>Epi-Off Continuous</arm_group_label>
    <arm_group_label>Epi-Off Pulsed</arm_group_label>
    <other_name>Vitamin B2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>UV Light - Continuous Beam</intervention_name>
    <description>5 minutes of constant UV exposure to saturated cornea</description>
    <arm_group_label>Epi-On Continuous</arm_group_label>
    <arm_group_label>Epi-Off Continuous</arm_group_label>
    <other_name>Peschke Vario CCL-365 UV system</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>UV Pulsed Beam</intervention_name>
    <description>5 minutes of UV exposure to saturated cornea, alternating 1 minute of treatment with 1 minute rest for a total time of 10 minutes</description>
    <arm_group_label>Epi-On Pulsed</arm_group_label>
    <arm_group_label>Epi-Off Pulsed</arm_group_label>
    <other_name>Peschke Vario CCL-365 UV system</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria Keratoconus:

          -  12 years of age or older

          -  Having a clinical diagnosis of progressive keratoconus consistent with:

               1. An increase of ≥ 1.00 D in the steepest keratometry value

               2. An increase of ≥ 1.00 D in astigmatism manifest refraction

               3. A myopic shift (decrease in the spherical equivalent) of ≥ 0.50 D on subjective
                  manifest refraction

          -  Presence of central or inferior steepening on the topography map.

          -  Axial topography consistent with keratoconus

          -  Steepest keratometry (Kmax) value ≥ 47.00 D

          -  Signed written informed consent

          -  Willingness and ability to comply with schedule for follow-up visits

          -  Contact lens removal prior to evaluation and treatment

        Inclusion Criteria Post-Surgical Ectasia:

          -  History of having undergone a keratorefractive procedure and:

               1. Steepening by topography

               2. Thinning of cornea

               3. Shift in the position of thinnest portion of cornea

               4. Change in refraction with increasing myopia

               5. Development of myopic astigmatism

               6. Development of irregular astigmatism

               7. Loss of Best Spectacle Corrected Visual Acuity

          -  At least two of the above criteria must be present.

        Inclusion Criteria Intacts:

          -  Should the patient have undergone prior Intacs or other intra-corneal ring segment
             surgery for keratoconus or post-surgical ectasia at least 6 months prior, and is also
             experiencing at least two of the above ectasia symptoms, they can be included in the
             study.

               1. These patients would have the choice of ring explant before Cross-Linking.

               2. Cross-Linking may still be performed if the patient wishes to retain the rings.

          -  Should a patient's situation due to factors such as significantly high myopia or
             astigmatism should warrant simultaneous placement of Intacs and cross-linking in the
             investigators opinion, then this option can be offered to the patient. Such
             interventions would be tracked as a different arm of the study.

        Inclusion Criteria RK/AK Fluctuation:

          -  History of having undergone radial keratotomy (RK) and or astigmatic keratotomy (AK)
             surgery.

          -  Expressing complaints about difficulties due to vision changing during the same day.

          -  A difference in their Manifest Refraction (MRx) of greater than 0.75 D measured on the
             same day, at least 6 hours apart.

          -  Intacs surgery will not be considered in patients with RK/AK.

        Exclusion Criteria:

          -  Eyes classified as either normal, atypical normal,

          -  Corneal pachymetry ≤ 350 microns at the thinnest point measured by Orbscan, Pentacam,
             or ultrasound in the eye to be treated

          -  A history of chemical injury or delayed epithelial healing in the eye to be treated.

          -  A known sensitivity to study medications

          -  Patients with significant nystagmus or any other condition that would prevent a steady
             gaze during the treatment

          -  Inability to cooperate with diagnostic tests.

          -  Patients with a current condition that, in the investigator's opinion, would interfere
             with or prolong epithelial healing.

          -  Taking Vitamin C (ascorbic acid) supplements within 1 week of the cross-linking
             treatment.

          -  Patients who are unable to remain comfortable and stable, and tolerate a lid speculum
             for the appointed period of time for the procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nancy A Tanchel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Liberty Laser Eye Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Travis A Johnson, Bachelor's</last_name>
    <phone>571-234-5678</phone>
    <phone_ext>104</phone_ext>
    <email>tjohnson@libertylasereye.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nancy A Tanchel, MD</last_name>
    <phone>571-234-5678</phone>
    <phone_ext>103</phone_ext>
    <email>ntanchel@libertylasereye.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>LaserVue Eye</name>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <zip>95403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jay Bansal, MD</last_name>
      <phone>707-522-6200</phone>
      <email>bansal@laservue.com</email>
    </contact>
    <investigator>
      <last_name>Jay Bansal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icon Lasik</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Richard Anderson, OD</last_name>
      <phone>720-524-1001</phone>
      <email>ra@icondenver.com</email>
    </contact>
    <investigator>
      <last_name>Douglas Campbell, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gulani Vision Institute</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arun Gulani, MD</last_name>
      <phone>904-296-7393</phone>
      <email>gulanivision@gulani.com</email>
    </contact>
    <investigator>
      <last_name>Arun Gulani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eye Consultants of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30339</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Teresa Long</last_name>
      <phone>404-351-2220</phone>
      <email>teresa_long@eyeconsultants.net</email>
    </contact>
    <investigator>
      <last_name>W. Barry Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Midwest Center for Sight</name>
      <address>
        <city>Des Plaines</city>
        <state>Illinois</state>
        <zip>60016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James Katz, MD</last_name>
      <phone>847-824-3127</phone>
      <email>jamesakatz@aol.com</email>
    </contact>
    <investigator>
      <last_name>James Katz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bond Eye Associates</name>
      <address>
        <city>Pekin</city>
        <state>Illinois</state>
        <zip>61554</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>William Bond, MD</last_name>
      <phone>309-353-6660</phone>
      <email>pekineye@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>William Bond, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Discover Vision Center</name>
      <address>
        <city>Leawood</city>
        <state>Kansas</state>
        <zip>66211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Misty Robe, Associate's</last_name>
      <phone>816-478-1230</phone>
      <email>mrobe@discovervision.com</email>
    </contact>
    <investigator>
      <last_name>John Doane, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Eye Center</name>
      <address>
        <city>Hattiesburg</city>
        <state>Mississippi</state>
        <zip>39402</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cameron Griffith, MD</last_name>
      <phone>318-464-0306</phone>
      <email>csgriff1@earthlink.net</email>
    </contact>
    <investigator>
      <last_name>Cameron Griffith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Clinic Eye Specialists</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stephanie Sekscinski</last_name>
      <phone>417-820-9393</phone>
      <email>stephanie.sekscinski@mercy.net</email>
    </contact>
    <investigator>
      <last_name>Shachar Tauber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LASIK of Nevada</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Valerie Serett</last_name>
      <phone>702-636-2010</phone>
      <email>vserette@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Richard Rothman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rajy Rouweyha, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>James Lewis MD PC</name>
      <address>
        <city>Elkins Park</city>
        <state>Pennsylvania</state>
        <zip>19027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James Lewis, MD</last_name>
      <phone>215-886-9090</phone>
      <email>jslewis@jameslewis.com</email>
    </contact>
    <investigator>
      <last_name>James Lewis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Eye Institute</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sherrie Reed</last_name>
      <phone>717-657-2020</phone>
      <email>crosslinkstudy@memorialeye.com</email>
    </contact>
    <investigator>
      <last_name>Bennett Chotiner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erik Chotiner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolina Eye Care</name>
      <address>
        <city>Mt. Pleasant</city>
        <state>South Carolina</state>
        <zip>29464</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Helga Sandoval, MD</last_name>
      <phone>843-881-3937</phone>
      <email>helga.sandoval@carolinaeyecare.com</email>
    </contact>
    <investigator>
      <last_name>Kerry Solomon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlene Grice, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loden Vision Centers</name>
      <address>
        <city>Goodlettsville</city>
        <state>Tennessee</state>
        <zip>37072</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katie Lambeth</last_name>
      <phone>615-859-3937</phone>
      <email>klamberth@lodenvision.com</email>
    </contact>
    <investigator>
      <last_name>James Loden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Parkhurst NuVision</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amy Ford</last_name>
      <phone>210-428-6788</phone>
      <email>nuvision.amy@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Gregory D Parkhurst, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liberty Laser Eye Center</name>
      <address>
        <city>Vienna</city>
        <state>Virginia</state>
        <zip>22182</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Travis A Johnson, Bachelor's</last_name>
      <phone>571-234-5678</phone>
      <phone_ext>104</phone_ext>
      <email>tjohnson@libertylasereye.com</email>
    </contact>
    <investigator>
      <last_name>Nancy A Tanchel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2014</study_first_submitted>
  <study_first_submitted_qc>March 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2014</study_first_posted>
  <last_update_submitted>March 21, 2014</last_update_submitted>
  <last_update_submitted_qc>March 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>crosslinking</keyword>
  <keyword>cornea</keyword>
  <keyword>keratoconus</keyword>
  <keyword>ectasia</keyword>
  <keyword>irradiance</keyword>
  <keyword>riboflavin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Riboflavin</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

